Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Nanoparticle Uptake Pathways in Human Corneal Cells
2026-08-25
Azadi and David examined how nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells using engineered PLGA nanoparticles and a mucosal in vitro model. The study linked particle properties to pathway-level behavior, identifying energy-dependent uptake dominated by macropinocytosis and caveolae-mediated endocytosis rather than phagocytosis.
-
Septin4, VHL, and HIF-1α in Cardiomyocyte Apoptosis
2026-08-25
The 2021 Cell Death Discovery study identifies HIF-1α as a Septin4-interacting protein and shows that Septin4 promotes VHL-dependent HIF-1α degradation during hypoxic cardiomyocyte injury. These findings place Septin4 upstream of a key oxygen-adaptation pathway and suggest a mechanistic explanation for its proapoptotic activity in myocardial hypoxia.
-
Temozolomide in DNA Repair and Glioma Research
2026-08-24
Temozolomide provides a controlled methylation-based DNA damage model for glioma, cancer biology, and chemotherapy resistance studies. This guide translates its chemistry into practical dosing, combination, readout, and troubleshooting workflows, including ATRX-informed assays inspired by recent high-grade glioma research.
-
Tetraethylammonium chloride in Cell Assays
2026-08-24
This scenario-based guide explains how Tetraethylammonium chloride, SKU B7262, can strengthen mechanistic interpretation in cell viability, proliferation, cytotoxicity, and potassium-channel studies. It connects assay design, solution handling, data interpretation, and vendor qualification to documented chemical and quality-control information.
-
ARCA Cy5 EGFP mRNA: Assay Architecture
2026-08-23
ARCA Cy5 EGFP mRNA (5-moUTP) enables researchers to separate cellular delivery from protein expression in a single reporter system. This guide presents an assay-design framework for interpreting Cy5, EGFP, trafficking, translation, and immune-response data in mammalian cells.
-
E-64d at the Proteostasis Decision Point
2026-08-22
E-64d is a membrane-permeable cysteine protease inhibitor that helps separate calpain- and cathepsin-dependent phenotypes from autophagic or proteasomal degradation. This article translates a recent Arabidopsis autophagy study into practical assay decisions without treating E-64d as a nonspecific substitute for genetic pathway analysis.
-
Betaine Hydrochloride for Translational Assays
2026-08-22
Betaine hydrochloride can be used as a deliberately controlled variable in enzyme, protease, cell culture, and molecular biology workflows—not merely as a soluble reagent. This guide connects practical assay design with the inflammation-focused esophageal cancer study of oridonin while clearly separating published findings from recommended validation experiments.
-
BOP Reagent in Translational Prodrug Design
2026-08-21
A mechanistic and strategic guide to using BOP reagent in peptide and prodrug workflows, with a clear evidence bridge to carrier-free, ROS-responsive triterpene systems investigated for oral squamous cell carcinoma.
-
DiscoveryProbe Bioactive Compound Library Plus for TSA
2026-08-20
Pair a broad, pre-dissolved small-molecule collection with thermal shift assay design to move from ligand discovery to pathway-level validation. The workflow combines bacterial sensor-protein biophysics, orthogonal binding confirmation, and cell-based follow-up for more defensible screening decisions.
-
Novel Ziprasidone Impurity: Methods and Significance
2026-08-20
The reference study identified and structurally characterized methylene ziprasidone dimer, an unknown process-related impurity detected during ziprasidone hydrochloride scale-up. Its combined HPLC, HRMS, and multidimensional NMR workflow provides a practical model for investigating low-level impurities that may affect pharmaceutical quality assessment.
-
APEX2 Enables Efficient TERT Expression in Stem Cells
2026-08-19
A 2024 preprint identifies APEX2 as a DNA repair enzyme required for efficient TERT expression and telomerase activity in human embryonic stem cells, with similar evidence in a melanoma cell line. Its RNA-seq and chromatin-binding results suggest that repair of damage-prone repetitive DNA within the TERT locus, rather than strong promoter occupancy, may connect APEX2 to gene regulation.
-
Trelagliptin, RUNX2, and Osteoblast Differentiation
2026-08-19
The reference study identifies a previously underexplored effect of the DPP-4 inhibitor trelagliptin: promotion of osteoblastic differentiation and mineralization in MC3T3-E1 cells. Its data connect this phenotype to increased RUNX2 and AMPK signaling, offering a mechanistic rationale for further osteoporosis research while remaining limited to an in vitro model.
-
Gly-Gly-Phe-Gly (GGFG) Workflow Guide
2026-08-18
Gly-Gly-Phe-Gly is a defined, glycine-rich peptide spacer for modular drug conjugation research, peptide engineering, and biomaterial construction. This practical guide covers dissolution, coupling design, analytical verification, assay selection, and troubleshooting without confusing linker performance with evidence from unrelated therapeutic studies.
-
BOP Reagent for Peptide Prodrug Workflows
2026-08-18
Learn how BOP reagent supports carboxyl group activation, phenyl ester preparation, blocked amino acid derivatives, and amide bond formation in research-scale synthesis. The workflow also explains how this chemistry can be evaluated prospectively in triterpene-based prodrug programs inspired by recent oral squamous cell carcinoma research.
-
Fumagillin Against Azumiobodo hoyamushi
2026-08-17
The reference study compared 20 antiprotozoal, antibiotic, antifungal, oxidizing, and halogen-based agents against Azumiobodo hoyamushi, identifying Fumagillin as moderately active in vitro. Its two-stage design also showed why parasite killing in culture must be separated from host-compatible disinfection: formalin and chlorine dioxide reduced parasite burdens in experimentally infected ascidians, whereas Fumagillin was not advanced to the in vivo phase.